Arthritis and Rheumatism Associates, P.C.

Vaccine Guidance

Updated June 17, 2021

The physicians of Arthritis & Rheumatism Associates encourage our patients to obtain any of the COVID-19 vaccines as they become available. Based on the data for the COVID-19 vaccines available in the U.S., there is no preference for one COVID-19 vaccine over another.

We support the new (2/10/2021) guidance from the American College of Rheumatology regarding how to take various medications around the time of COVID-19 vaccinations that use mRNA (by Pfizer and Moderna):

If you take ibuprofen, naproxen, other NSAIDs, or Tylenol, and your rheumatologic disease is doing well, do not take them for 24 hours prior to vaccination (no restrictions on use post-vaccination).

If you take any of the following medications, and your rheumatologic disease is doing well, do not take this medication for 1 week after each dose of COVID-19 vaccine:

Xeljanz (tofacitinib)

Rinvoq (upadacitinib)

Olumiant (baricitinib)

If you take methotrexate, and your rheumatologic disease is doing well:

Do not take methotrexate and Cellcept (mycophenolate)  for 1 week after each of the mRNA vaccine doses (Pfizer, Moderna)

Do not take methotrexate for 2 weeks after single-dose vaccine (Johnson & Johnson)

If you take the following medications, contact ARA when you are nearing the time of your COVID-19 vaccination to plan scheduling the doses: 

Orencia (abatacept)

Rituxan (rituximab)

Cyclophosphamide intravenous only (Cytoxan)

If you take the following medications, you do not have to change your medication dosing schedule around the time of COVID-19 vaccination: 

 

Actemra

Guselkumab (Tremfya)

Sarilumab (Kevzara)

Adalimumab (Humira)

Humira

Secukinumab (Cosentyx)

Anakinra (Kineret)

hydrocortisone

Simponi

Apremilast (Otezla)

Hydroxychloroquine (Plaquenil)

Simponi Aria

Arava (leflunomide)

Ilaris

Skyrizi

Azathioprine (Imuran)

Imuran

Stelara

Belimumab (Benlysta)

Infliximab (Remicade, Inflectra, Renflexis) 

Sulfasalazine

Benlysta

Ixekizumab (Taltz)

Tacrolimus

Canakinumab (Ilaris)

Kevzara

Taltz

Certolizumab (Cimzia)

Kineret

Tocilizumab (Actemra)

Cimzia

Leflunomide

Tremfya

Cosentyx

Lupkynis

Ustekinumab (Stelara)

Cyclophosphamide oral only (Cytoxan)

Otezla

Voclosporin (Lupkynis)

cyclosporine

   Prednisone

Zoledronic acid (Reclast)

Cytoxan (oral only)

Prolia

 

Denosumab (Prolia)

Reclast

 

Enbrel

Remicade

 

Etanercept (Enbrel)

Rizankizumab (Skyrizi)

 

Evenity

Romosozumab (Evenity)

 

 

 

 

 

Reference link: American College of Rheumatology COVID-19 Vaccine Clinical Guidance Summary for Patients with Rheumatic and Musculoskeletal Diseases.

   

View Full Site
Top